Knowledge of appropriate blood product use in perioperative patients among clinicians at a tertiary hospital

Abstract

Seventy percent correctly identified triggers for RCC transfusion and 50% for platelets.Administration protocols were correctly defined by 80% for RCC and FFP just over 50% for platelets. Thirty eight percent of respondents deemed infectious and non-infectious risk sufficient to obtain informed consent. Knowledge of costs and ordering was below 30%. Conclusion:Clinician's knowledge of risks, resources, costs and ordering of blood products for perioperative patients is poor. Transfusion triggers and administration protocols had an acceptable correct response rate.

Do advanced clinical practitioners have the theoretical knowledge to authorise blood components for transfusion? A cross sectional survey Study

“…Of those studies that included haematologists within their sample (n = 6) this was a similar finding, (2014). The studies that did not include haematology but looked at more than one speciality within their sample also found that anaesthetists scored the highest out of all other specialities within the survey (Yudelowitz et al, 2016, Kasraian and Tavassoli, 2014, Philip et al, 2015and Kumarage et al, 2016 Respondents from certain specialities scored differently perhaps due to their clinical exposure to blood component practices. Haematology are the largest specialist users of red cells within the UK (NHSPT, 2014).…”

“…A Literature review was undertaken prior to commencement of the study in order to ground the study in the context of existing knowledge. There were 12 studies identified which included a total of 4,275 participants from 11 different countries (Abdi et al, 2017, Alvarado-Navarro et al, 2016, Kumarage et al, 2016, Mayaki et al, 2016, Yudelowitz et al, 2016, Haspel et al, 2015, Graham et al, 2014, Kasraian and Tavassoli, 2014, Philip et al, 2015, Gharehbaghian et al, 2009, Rock et al, 2002and Morris et al, 2016. These studies focused on investigating the broad knowledge requirements around safe authorisation of blood components as opposed to specific areas, such as transfusion reactions, administration or public knowledge.…”